Development of an ectopic site for islet transplantation, using biodegradable scaffolds

Tissue Engineering

Volumn 11, Issue 9-10, 2005, Pages 1323-1331

  Dufour, Jannette M ^a   Rajotte, Ray V ^a   Zimmerman, Mark ^b   Rezania, Alireza ^b   Kin, Tatsuya ^a   Dixon, Doreen E ^a   Korbutt, Gregory S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; BIOLOGICAL ORGANS; CELLS; GLUCOSE; METABOLISM; SCAFFOLDS;

BIODEGRADABLE SCAFFOLDS; ISLETS; NORMOGLYCEMIA; POSTTRANSPLANTATION;

TRANSPLANTATION (SURGICAL);

GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DIABETES MELLITUS; EPIDIDYMIS FAT; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HYPERGLYCEMIA; KIDNEY CAPSULE; MALE; METABOLISM; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; AREA UNDER CURVE; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; BLOOD GLUCOSE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; FASTING; GLUCAGON; GLUCOSE; GLUCOSE TOLERANCE TEST; GRAFT SURVIVAL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY; LAMININ; MALE; MICE; MICE, INBRED BALB C; POLYGLACTIN 910; POLYMERS; PROTEOGLYCANS; TIME FACTORS; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 27744487031     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.1323     Document Type: Article

References (30)

1. Shapiro, A.M.J., Lakey, J.R.T., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M., and Rajotte, R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regime. N. Engl. J. Med. 343, 230, 2000.
2. Ryan, E.A., Lakey, J.R.T., Rajotte, R.V., Korbutt, G.S., Kin, T., Imes, S., Rabinovitch, A., Elliot, J.F., Bigam, D., Kneteman, N.M., Warnock, G.L., Larsen, I., and Shapiro, A.M. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50, 710, 2001.
3. Ryan, E.A., Lakey, J.R.T., Paty, B.W., Imes, S. Korbutt, G.S., Kneteman, N.M., Bigam, D., Rajotte, R.V., and Shapiro, A.M. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51, 2148, 2002.
4. Shapiro, A.M.J., Gallant, H., Hao, E., Wong, J., Rajotte, R., Yatscoff, R., and Kneteman N. Portal vein immunosuppressant levels and islet graft toxicity. Transplant. Proc. 30, 641, 1998.
5. Bennet, W., Sundberg, B., Groth, C.G., Brendel, M.D., Brandhorst, D., Brandhorst, H., Bretzel, R.G., Elgue, G., Larsson, R., Nilsson, B., and Korsgren, O. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 48, 1907, 1999.
6. Miller, W.F.A., Klempnauer, J., Luck, R., and Steiniger, B. Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes 40, 134, 1991.
7. Warnock, G.L., DeGroot, T., Untch, D., Ellis, D.K., and Rajotte, R.V. The natural history of pure canine islet autografts in hepatic or splenic sites. Transplant. Proc. 21, 2617, 1989.
8. Hesse, U.J., Sutherland, D.E.R., Gores, P.F., Sitges-Serra, A., and Najarian, J.S. Comparison of splenic and renal subcapsular islet autografting in dogs. Transplantation 41, 271, 1986.
9. Warnock, G.L., Dabbs, K.D., Evans, M.G., Cattral, M.S., Kneteman, N.M., and Rajotte, R.V. Critical mass of islets that function after implantation in a large mammalian. Horm. Metab. Res. Suppl. 25, 156, 1990.
10. Kaufman, D.B., Morel, P., Field, M.J., Munn, S.R., and Sutherland, D.E.R. Purified canine islet autografts: Functional outcome as influenced by islet number and implantation site. Transplantation 50, 385, 1990.
11. Warnock, G.L., and Rajotte, R.V. Human pancreatic islet transplantation. Transplant. Rev. 6, 195, 1992.
12. White, S.A., Davies, J.E., Pollard, C., Swift, S.M., Clayton, H.A., Sutton, C.D., Weymss-Holden, S., Musto, P.P., Berry, D.P., and Dennison, A.R. Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Ann. Surg. 233, 423, 2001.
13. White, S.A., London, N.J.M., Johnson, P.R.V., Davies, J.E., Pollard, C., Contractor, H.H., Hughes, D.P., Robertson, G.S.M., Musto, P.P., and Dennison, A.R. The risks of total pancreatectomy and splenic islet autotransplantation. Cell Transplant. 9, 19, 2000.
14. Stock, U.A., and Vacanti, J.P. Tissue engineering: Current state and prospects. Annu. Rev. Med. 52, 443, 2001.
15. Wang, R.N., and Rosenberg, L. Maintenance of β cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J. Endocrinol. 163, 181, 1999.
16. Rosenberg, L., Wang, R., Paraskevas, S., and Maysinger, D. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 126, 393, 1999.
17. Korbutt, G.S., Suarez-Pinzon, W., Power, R., Rajotte, R.V., and Rabinovitch, A. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice. Diabetologia 43, 474, 2000.
18. Dufour, J.M., Rajotte, R.V., Kin, T., and Korbutt, G.S. Immunoprotection of rat islet xenografts by cotransplantation with Sertoli cells and a single injection of antilymphocyte serum. Transplantation 75, 1594, 2003.
19. Dufour, J.M., Rajotte, R.V., and Korbutt, G.S. Development of an in vivo model to study testicular morphogenesis. J. Androl. 23, 635, 2002.
20. Korbutt, G.S., Elliot, J.F., Ao, A., Smith, D.K., Warnock, G.L., and Rajotte, R.V. Large scale isolation, growth, and function of porcine neonatal islet cells. J. Clin. Invest. 97, 2119, 1996.
21. Tung, P.S., and Fritz, I.B. Characterization of rat testicular peritubular myoid cells in culture: α-Smooth muscle isoactin is a specific differentiation marker. Biol. Reprod. 42, 351, 1990.
22. Kin, T., Korbutt, G.S., and Rajotte, R.V. Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am. J. Transplant. 3, 281, 2003.
23. Ao, Z., Matayoshi, K., Lakey, J.R.T., Rajotte, R.V., and Warnock, G.L. Survival and function of purified islets in the omental pouch of outbred dogs. Transplantation 56, 524, 1993.
24. Yasunami, Y., Lacy, P.E., and Finke, E.H. A new site for islet transplantation: A peritoneal-omental pouch. Transplantation 36, 181, 1983.
25. Guan, J., Behme, M.T., Zucker, P., Atkison, P., Hramiak, I., Zhong, R., and Dupre, J. Glucose turnover and insulin sensitivity in rats with pancreatic islet transplants. Diabetes 47, 1020, 1998.
26. Juang, J.H., Bonner-Weir, S., Ogawa, Y., Vancanti, J.P., and Weir, G.C. Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 61, 1557, 1996.
27. Cameron, D.F., Hushen, J.J., and Nazian, S.J. Formation of insulin-secreting, Sertoli-enriched tissue constructs by microgravity coculture of isolated pig islets and rat Sertoli cells. In Vitro Cell Dev. Biol. Anim. 37, 490, 2001.
28. 1-dependent mechanism. Diabetes 49, 1810, 2000.
29. Korbutt, G.S., Elliott, J.F., and Rajotte, R.V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46, 317, 1997.
30. Selawry, H.P., and Cameron, D.F. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Tranplant. 2, 123, 1993.